|
Teijin Pharma inks bronchial asthma pact with Pulmagen
Pharma Times The number of people in Japan suffering from bronchial asthma has nearly doubled to more than eight million adults and children over the past 10 years. Although mortality is declining, more than 2,000 people, mainly elderly, still die from the … Japan,United Kingdom : Teijin Pharma and Pulmagen Therapeutics Sign … Teijin to develop and market bronchial asthma drug in Japan |
View full post on asthma – Google News